Shen-Yuan-Dan Capsule Attenuates Verapamil-Induced Zebrafish Heart Failure and Exerts Antiapoptotic and Anti-Inflammatory Effects via Reactive Oxygen Species-Induced NF-κB Pathway

Background: Heart failure (HF) is the end stage of ischemic cardiovascular diseases; nonetheless, safe and effective therapeutic agents for HF are still lacking, and their discovery remains challenging. Our previous studies demonstrated that Shen-Yuan-Dan Capsule (SYDC), a hospital preparation of tr...

Full description

Saved in:
Bibliographic Details
Main Authors: Sinai Li (Author), Hongxu Liu (Author), Yue Li (Author), Xiaomei Qin (Author), Mengjie Li (Author), Juju Shang (Author), Wenlong Xing (Author), Yanbing Gong (Author), Weihong Liu (Author), Mingxue Zhou (Author)
Format: Book
Published: Frontiers Media S.A., 2021-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_0f5c76aef6fd496bb6f15e97ea2f31b4
042 |a dc 
100 1 0 |a Sinai Li  |e author 
700 1 0 |a Hongxu Liu  |e author 
700 1 0 |a Yue Li  |e author 
700 1 0 |a Xiaomei Qin  |e author 
700 1 0 |a Mengjie Li  |e author 
700 1 0 |a Juju Shang  |e author 
700 1 0 |a Wenlong Xing  |e author 
700 1 0 |a Yanbing Gong  |e author 
700 1 0 |a Weihong Liu  |e author 
700 1 0 |a Mingxue Zhou  |e author 
245 0 0 |a Shen-Yuan-Dan Capsule Attenuates Verapamil-Induced Zebrafish Heart Failure and Exerts Antiapoptotic and Anti-Inflammatory Effects via Reactive Oxygen Species-Induced NF-κB Pathway 
260 |b Frontiers Media S.A.,   |c 2021-03-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2021.626515 
520 |a Background: Heart failure (HF) is the end stage of ischemic cardiovascular diseases; nonetheless, safe and effective therapeutic agents for HF are still lacking, and their discovery remains challenging. Our previous studies demonstrated that Shen-Yuan-Dan Capsule (SYDC), a hospital preparation of traditional Chinese herbal, effectively protected ischemic injury in cardiovascular diseases. However, its therapeutic effects and possible mechanisms on HF remain unclear.Methods: A zebrafish HF model treated with verapamil was developed to assess the therapeutic effect of SYDC on HF zebrafish. Zebrafish were administered with SYDC and digoxin (positive control) by direct soaking. After drug treatment, zebrafish were randomly assigned to the visual observation and image acquisition using a Zebralab Blood Flow System. The reactive oxygen species (ROS), MDA, and SOD levels were determined by fluorescence signal detection, TBA, and WST-8 methods. RT-PCR determined the mRNA expressions of Caspase-3, Caspase-1, Bcl-2, Bax, IL-1β, NF-κB, and TNF-α.Results: SYDC significantly inhibited the levels of heart dilatation and venous congestion and markedly increased the levels of cardiac output, blood flow dynamics, and heart rates in HF zebrafish (p < 0.05, p < 0.01, and p < 0.001). Moreover, SYDC also significantly decreased the levels of MDA and ROS and increased the level of SOD in HF zebrafish. The RT-PCR results revealed that SYDC decreased the expression of Caspase-1, Caspase-3, Bax, IL-1β, NF-κB, and TNF-α but increased the expression of Bcl-2 in HF zebrafish (p < 0.05, p < 0.01, and p < 0.001).Conclusions: SYDC improved the heart function in verapamil-induced HF zebrafish and alleviated inflammation and apoptosis by inhibiting the ROS-mediated NF-κB pathway. 
546 |a EN 
690 |a heart failure 
690 |a zebrafish 
690 |a apoptosis 
690 |a inflammation 
690 |a NF-κB pathway 
690 |a Shen-Yuan-Dan capsule 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 12 (2021) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2021.626515/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/0f5c76aef6fd496bb6f15e97ea2f31b4  |z Connect to this object online.